Caribou Biosciences Inc. (CRBU)
NASDAQ: CRBU
· Real-Time Price · USD
1.85
-0.04 (-2.12%)
At close: Sep 04, 2025, 3:59 PM
1.87
1.07%
After-hours: Sep 04, 2025, 07:19 PM EDT
Caribou Biosciences Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 |
|---|---|---|
| Reportable Segment Revenue | 2.67M | 2.35M |
| Reportable Segment Revenue Growth | +13.34% | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Us Revenue | 1M | 129K | 197K | 367K | 20K | 160K | 1.2M | 377K | 9K | 117K | 150K | 337K | 9K | 52K | 129K | 3.51M | 1.48M |
| Non-Us Revenue Growth | +679.07% | -34.52% | -46.32% | +1735.00% | -87.50% | -86.71% | +219.36% | +4088.89% | -92.31% | -22.00% | -55.49% | +3644.44% | -82.69% | -59.69% | -96.32% | +137.60% | n/a |
| United States Revenue | 1.66M | 2.22M | 5.34M | 1.66M | 3.44M | 2.27M | 2.35M | 23.29M | 3.75M | 3.38M | 3.54M | 2.97M | 4.18M | 2.61M | 2.43M | n/a | n/a |
| United States Revenue Growth | -25.27% | -58.38% | +222.51% | -51.89% | +51.78% | -3.61% | -89.89% | +521.60% | +10.66% | -4.43% | +19.42% | -29.09% | +60.15% | +7.49% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 10.4M | 9.73M | 10.49M | 9.84M | 10.63M | 14.64M | 7.75M | 9.71M | 10.12M | 8.91M | 8.53M | 9.85M | 10.04M | 9.59M | 7.85M | 6.76M | 5.11M | 4.6M | 4.17M | 3.25M | 3.15M | 3.49M |
| Selling, General, and Administrative Revenue Growth | +6.86% | -7.18% | +6.57% | -7.41% | -27.41% | +89.02% | -20.22% | -4.04% | +13.59% | +4.39% | -13.35% | -1.94% | +4.70% | +22.16% | +16.17% | +32.21% | +11.25% | +10.14% | +28.52% | +2.98% | -9.63% | n/a |
| Research and Development Revenue | 27.69M | 35.53M | 30.46M | 30.42M | 35.48M | 33.79M | 31.28M | 28.58M | 26.5M | 25.71M | 25.74M | 19.99M | 22.58M | 13.92M | 15.11M | 15.83M | 12.33M | 10.16M | 12.02M | 6.18M | 7.58M | 8.64M |
| Research and Development Revenue Growth | -22.06% | +16.63% | +0.14% | -14.26% | +5.01% | +8.02% | +9.43% | +7.85% | +3.09% | -0.10% | +28.74% | -11.46% | +62.16% | -7.86% | -4.56% | +28.44% | +21.27% | -15.46% | +94.56% | -18.47% | -12.28% | n/a |